Home > Financial Ratios > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   Fixed Capital/Sales(x) 0.082.202.010.61

What is the latest Fixed Capital/Sales ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?

The latest Fixed Capital/Sales ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is 0.08 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20260.08
Mar20252.20
Mar20242.01
Mar20230.61

How is Fixed Capital/Sales of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?

Years Fixed Capital/Sales % Change
Mar2026 0.08
-96.36
Mar2025 2.2
9.45
Mar2024 2.01
229.51
Mar2023 0.61 -

Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY


Compare Fixed Capital/Sales ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹6,363.4 Cr -4.9% -3.9% 39.5% Stock Analytics
PRIME FOCUS ₹24,188.7 Cr -0.6% 12.9% 79.8% Stock Analytics
SAGILITY ₹21,136.2 Cr -1.7% 5.8% 6.1% Stock Analytics
SYNGENE INTERNATIONAL ₹15,446.4 Cr -1.8% -4.7% -40.8% Stock Analytics
INDEGENE ₹13,929.1 Cr -3.6% 1.5% 4.3% Stock Analytics
INTERNATIONAL GEMOLOGICAL INSTITUTE ₹13,578.5 Cr -1.1% -9% -11.2% Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

-4.9%

-3.9%

39.5%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses